480-567-1629 Call Us

EMSELLA by BTL Industries is an FDA-cleared, noninvasive treatment for urinary incontinence and pelvic floor weakness. Using High-Intensity Focused Electromagnetic (HIFEM) technology, EMSELLA strengthens the pelvic floor muscles from the inside out — while you remain fully clothed, seated comfortably in a chair.

Reduced urine leakage during coughing, sneezing, laughing, and physical activity
Significant improvement on the 1-hour pad test when HIFEM is combined with pelvic floor muscle training

Improved bladder control and reduced urgency episodes
Better urination control reported by patients after treatment

A pilot randomized controlled trial in postpartum women with SUI found that HIFEM combined with pelvic floor muscle training significantly reduced urine leakage on the 1-hour pad test, supporting its role in postnatal rehabilitation

HIFEM induces deep pelvic floor muscle contractions that have been shown to increase bioelectrical muscle activity on surface electromyography, with effects demonstrated in a sham-controlled randomized study

Patients report meaningful improvements across multiple quality-of-life domains, including physical limitations, social limitations, personal relationships, and emotional well-being
A randomized controlled trial of 128 women found that electromagnetic pelvic floor stimulation significantly reduced depressive symptoms and improved self-efficacy beliefs alongside incontinence improvement

Among sexually active women, HIFEM therapy has been associated with improvements in arousal, orgasm, and reduced condition-related impact on intimacy
A systematic review of chair-based magnetic stimulation found clinically relevant improvements in Female Sexual Function Index (FSFI) scores, with gains of +6.3 to +10.0 points across studies
Patients have also reported increased sexual desire and better overall satisfaction following treatment

EMSELLA delivers focused electromagnetic energy directly to the pelvic floor, triggering thousands of supramaximal muscle contractions per session. These contractions drive deep neuromuscular stimulation, pelvic floor remodeling, and restoration of continence control.

Emerging evidence supports its use in men with urinary incontinence following radical prostatectomy:
EMSELLA may offer a complementary approach for men with SSRI-induced ED by:
Pelvic floor muscle rehabilitation has also shown promise for premature ejaculation. Strengthening the bulbospongiosus and ischiocavernosus muscles through targeted contractions may improve ejaculatory control, with clinical studies demonstrating intracavernous pressure gains in men with premature ejaculation comparable to those seen in ED patients.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.